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Increased urine albumin concentration (UALB) or urine albumin-to-creatinine ratio
(UACR) at admission has been associated with systemic disease and increased morbidity 
and mortality in critically ill canine patients. The objective of  this study was to assess the 
prognostic value of  UALB and UACR for the survival, as well as for the development 
and duration of  systemic infl ammatory response syndrome (SIRS) in puppies with 
canine parvoviral enteritis (CPVE). Unvaccinated puppies, aged 1-12 months with 
confi rmed CPVE, hospitalized for ≥5 days were included. Urine was collected at 
admission via cystocentesis; albumin was measured immunoturbidimetrically and 
creatinine spectrophotometrically. The presence of  SIRS was daily evaluated. Statistical 
analysis was conducted using R language. Twenty-six dogs were enrolled; 12/26 (46%) 
developed SIRS during hospitalization, while 5/26 (19%) died. A signifi cant correlation 
was found between UALB and UACR (ρ=0.868, p<0.001). The dogs with SIRS had 
higher median UALB [0.5 (0-12.7) mg/dL] and UACR [4.2 (0-2,093) mg/g] compared 
to dogs without SIRS [UALB= 0.1 (0-0.8) mg/dL, UACR= 1.6 (0-5.6) mg/g], but the 
differences were non-signifi cant (p>0.05). SIRS duration was signifi cantly correlated 
with UACR (ρ=0.427, p=0.030), but not with UALB (ρ=0.386, p=0.052). The non-
survivors had higher median UALB [0.6 (0.1-12.7) mg/dL] and UACR [19.6 (0.7-2,093) 
mg/g] compared to survivors [UALB= 0.2 (0-1.5) mg/dL, UACR= 2.3 (0-16.9) mg/g], 
but the differences were non-signifi cant (p>0.05). UACR appears to be a prognostic 
indicator of  SIRS duration in puppies with CPVE. However, a large-scale study is 
warranted to confi rm the usefulness of  UALB and UACR for clinical risk assessment 
in puppies with CPVE.
Key words: dog, infl ammation, SIRS, systemic infl ammatory response syndrome, urine 
albumin, urine creatinine
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INTRODUCTION
Canine parvoviral enteritis (CPVE) is one of  the most common infectious disorders 
and a signifi cant cause of  morbidity and mortality in dogs younger than 6 months [1]. 
The etiological agent, canine parvovirus (CPV)-2, is a small, non-enveloped DNA 
virus with tropism to rapidly dividing cells, which can naturally infect almost all Canidae 
species [1].
Dogs with CPVE often develop systemic infl ammatory response syndrome (SIRS), 
which can eventually lead to multiple organ dysfunction syndrome and death [2]. 
Studies in human medicine have shown that SIRS and sepsis are characterized by 
massive production of  pro-infl ammatory cytokines and activation of  coagulation 
cascade, subsequently leading to increased vascular permeability [3,4]. The latter may 
be associated with increased urinary excretion of  plasma proteins [5,6]. Increased 
urine albumin concentration (UALB) or urine albumin-to-creatinine ratio (UACR) 
at admission has been associated with systemic disease in dogs and cats [7,8] and 
increased morbidity and mortality in critically ill human and canine patients [9,10].
Our hypothesis was that UALB and UACR measured at admission, act as prognostic 
indicators of  the outcome, SIRS development, and SIRS duration in puppies with 
CPVE. Therefore, the aim of  this study was to assess the prognostic value of  UALB 
and UACR for the survival, as well as the development and duration of  SIRS in 
puppies with CPVE.
MA TERIALS AND METHODS
The present study took place at the Clinic of  Companion Animals, School of  
Veterinary Medicine, Faculty of  Health Sciences, Aristotle University of  Thessaloniki, 
Greece. The inclusion criteria were the following: a)  age between 1 to 12 months; b) no 
previous treatment and no vaccination against CPV during the preceding 2 weeks of  
admission; c) clinical signs compatible with CPVE; d) absence of  clinical or diagnostic 
imaging fi ndings indicative of  foreign body, intussusception, or other morphological 
abnormalities of  the gastrointestinal tract; e) positive ELISA fecal test for CPV 
antigen (Canine Parvovirus Antigen Test Kit, IDEXX Laboratories, Westbrook, 
USA) and positive PCR for CPV using a previously described method [11]; f) negative 
ELISA fecal test for Giardia antigen (Giardia Antigen Test Kit, IDEXX Laboratories, 
Westbrook, USA); g) negative fecal parasitological examination (fecal zinc sulphate 
fl otation) for intestinal parasites and protozoa performed at admission and every 48h; 
h) hospitalization for at least 5 days; i) owner’s written consent. 
In a ll dogs included in the present study, a complete physical examination was 
performed 3 times a day. Blood samples were collected daily via jugular venipuncture 
into K3EDTA tubes (Potassium - EDTA, Vet Collect tubes, IDEXX, UK) and a 
complete blood count was performed on the automated hematology analyzer Advia 120 
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(Siemens Healthcare Diagnostics, Deerfi eld, USA). Urine was collected at admission 
via cystocentesis; albumin concentration was measured using a previously validated 
method [12], while creatinine concentration was measured spectrophotometrically. 
Systemic infl ammatory response syndrome was defi ned as the presence of  at least 
three of  the following criteria: heart rate >140 beats/min, respiratory rate >30 
breaths/min, body temperature >39.2oC or <37.8oC, and total white blood cell count 
>17,000 cells/μL or <6,000/μL. The a forementioned criteria were daily evaluated for 
each dog during the hospitalization period. 
The da ta distribution was assessed using the Shapiro-Wilk test. The exact Wilcoxon 
rank-sum test was used for the median comparison between two independent groups, 
while the Spearman’s rank correlation coeffi cient was employed for the determination 
of  the correlation between two variables. Receiver operator characteristics (ROC) 
analysis was carried out to assess the performance of  UACR in predicting survival. 
The statistical analyses were conducted using R statistical language (R Foundation for 
Statistical Computing, Vienna, Austria).
Informed consent: informed consent has been obtained for client-owned animals 
included in this study.
RESULTS
In total, 26 dogs (12 males, 14 females) were enrolled in this study. The mean (± 
SD) age of  the canine population was 3.9±1.9 months. Forty-six percent (12/26) 
of  the puppies developed SIRS during hospitalization, while 19% (5/26) of  them 
died. A statistically signifi cant and very good positive correlation was found between 
UALB and UACR (ρ=0.868, p<0.001). The median (range) UALB was higher in dogs 
that developed SIRS during hospitalization [0.5 (0-12.7) mg/dL] compared to dogs 
without SIRS [0.1 (0-0.8) mg/dL]. Similarly, the median UACR was also higher in dogs 
that developed SIRS [4.2 (0-2,093) mg/g] compared to dogs without SIRS [1.6 (0-5.6) 
mg/g]. However, the observed differences for both UALB and UACR were statistically 
non-signifi cant (p=0.113 and p=0.107, respectively). No statistically signifi cant 
correlation was observed between UALB and SIRS duration (ρ=0.386, p=0.052), 
whereas a statistically signifi cant, moderate positive correlation was detected between 
UACR and SIRS duration (ρ=0.427, p=0.030). The median UALB was higher in non-
survivors [0.6 (0.1-12.7) mg/dL] compared to survivors [0.2 (0-1.5) mg/dL], but the 
difference was proven to be statistically non-signifi cant (p=0.123). The median UACR 
was also higher in dogs with negative outcome [19.6 (0.7-2,093) mg/g] compared to 
dogs with positive outcome [2.3 (0-16.9) mg/g], with the difference being statistically 
non-signifi cant though (p=0.087). The area under the ROC curve (AUC) for UACR 
was 0.752 (95% confi dence intervals: 0.443-1.000) for survival prediction (Figure 1). 
The optimal cut-off  value was 18.3 mg/g (sensitivity: 60%, specifi city: 100%).
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DISCUSSION
In the present study, the prognostic value of  UALB and UACR, measured at admission, 
for survival, SIRS development, and SIRS duration was investigated. Increased UALB 
or UACR at admission has been previously documented in dogs and cats with systemic 
disease [7,8] and have been related to increased morbidity and mortality in critically 
ill human and canine patients [9,10]. To the best of  our knowledge, the present study 
is the fi rst attempt to investigate the prognostic value of  UALB and UACR for the 
survival, as well as the development and duration of  SIRS in puppies naturally infected 
with CPVE.
Canine parvoviral enteritis is one of  the most important infectious diseases of  puppies 
due to its high prevalence and high mortality rate [1]. The intestinal tract damage by 
the CPV-2 and the compromised immune system increase the risk of  SIRS due to the 
hematogenous spread of  intestinal bacterial toxins and pro-infl ammatory cytokines, 
such as tumour necrosis factor [13]. In fact, SIRS is commonly documented in dogs 
with CPVE and can lead to multiple organ dysfunction syndrome and death [2].
Urine albumin was very well correlated with UACR; however, our results suggest that 
the latter may be a better prognostic indicator in puppies with CPVE. Urine albumin 
was devoid of  any prognostic value in puppies naturally infected with CPVE. On 
the other hand, a moderate positive correlation between UACR at admission and 
Figure 1. Outcome prediction receiver operating characteristics (ROC) curve for urine albumin-
to-creatinine ratio (UACR) for 26 puppies naturally infected with canine parvoviral enteritis. 
The green line is the ROC curve, while the black diagonal represents the null hypothesis. The 
area under the ROC curve is 0.752 (95% confi dence interval: 0.443-1.000).
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SIRS duration was demonstrated, indicating that UACR might be useful in predicting 
the duration of  SIRS in hospitalized puppies with CPVE. Altered urinary protein 
excretion has been previously documented in dogs with SIRS [14]; however, to our 
knowledge, this is the fi rst study reporting an association between UACR at admission 
with the duration of  SIRS in the hospitalization period.
The early phase of  acute infl ammation is characterized by increased vascular 
permeability, which allows the transmigration of  neutrophils and the leakage of  plasma 
proteins, including albumin. In human medicine, there are several experimental and 
clinical studies suggesting the increased vascular permeability as the mechanism that 
lies behind the association between microalbuminuria and SIRS. Specifi cally, increased 
transcapillary leakage rate of  radiolabelled albumin has been found in human patients 
with sepsis, neoplasia, or after cardiac surgery [5]. Systemic endothelial dysfunction 
has also been associated with albumin transcapillary leakage rate and urine albumin 
in patients with diabetes or hypertension [15]. Furthermore, in a clinical setting, it has 
been documented that UALB was associated with the severity of  infl ammatory events 
[16].
Although, UALB and UACR were higher in dogs with negative outcome compared to 
dogs with positive outcome, the observed differences were proven to be statistically 
non-signifi cant. Nonetheless, it is worthy of  mentioning that UACR was signifi cantly 
higher in non-survivors at 0.10 signifi cance level compared to survivors. Thus, the 
results of  this pilot study should be interpreted cautiously, especially in the context of  
a small sample size. The substandard AUC for UACR was similar to that previously 
reported in critically ill dogs [10]. The calculated optimal cut-off  value of  18.3 mg/g is 
characterized by excellent specifi city (100%), but lacks a substantial sensitivity (60%).
In conclusion, our results are suggestive of  the potentially adjunct role of  UACR in 
predicting SIRS duration and survival in puppies with CPVE. Nevertheless, this study 
shares a limitation with other pilot studies, which is the small sample size. However, it 
could be a trigger for a large-scale prospective study, which is warranted to confi dently 
determine the usefulness of  microalbuminuria for clinical risk assessment in puppies 
with CPVE.
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PROGNOSTIČKI ZNAČAJ MIKROALBUMINURIJE KOD 
ŠTENADI SA PARVOVIRUSNIM ENTERITISOM
OIKONOMIDIS Ioannis L., SOUBASIS Nectarios, CERON Jose Joaquin,
THEODOROU Konstantina, RALLIS Timoleon, POLIZOPOULOU Zoe
Povećane koncentracije albumina u mokraći (UALB) odnosno albumin-kreatin odnos 
u urinu (UARC) je povezan sa sistemskim oboljenjima i povećanim morbiditetom i 
mortalitetom kod kritično obolelih pasa. Cilj studije je bio da se proceni progenostički 
značaj UALB i UACR u odnosu na stepen preživljavanja, kao i razvoj sindroma 
sistemskog zapaljenskog odgovora (SIRS) i dužine trajanja kod štenadi obolelih od 
parvovirusnog enteritisa (CPVE). Posmatrani su nevakcinisani štenci, starosti 1-12 
meseci, sa potvrđenim CPVE, koji su bili hospitalizovani ≥5 dana. Urin je sakupljan 
cistocentezom, prilikom prijema životinja u bolnicu; obavljano je imunoturbidimetri-
jsko merenje albumina uz spektrofotometrijsko određivanje kreatinina. Svakodnevno 
je određivano prisustvo SIRS. Statistička analiza je obavljana upotrebom R-jezika. 
Obrađeno je 26 pasa: 12/26 (46%) je razvilo SIRS tokom hospitalizacije, pri čemu 
je 5/26 (19%) uginulo. Značajna korelacija je uočena između UALB i UARC (p=868, 
p<0,001). Psi sa SIRS su imali veće prosečne vrednosti UALB [0,5 (0-12,7) mg/dL] i 
UACR [4,2 (0-2,093) mg/g] u poređenju sa psima bez SIRS [UALB= 0,1 (0-0,8) mg/
dL, UACR= 1,6 (0-5,6) mg/g], ali je razlika bila statistički beznačajna (p>0,05). Tra-
janje SIRS je bilo u statistički značajnoj korelaciji sa UACR (ρ=0,427, p=0,030), ali ne 
i sa UALB (ρ=0,386, p=0,052). Životinje koje nisu preživele oboljenje imale su veće 
srednje vrednosti UALB [0,6 (0,1-12,7) mg/dL] and UACR [19,6 (0,7-2,093) mg/g] u 
poređenju sa psima koji su preživeli [UALB= 0,2 (0-1,5) mg/dL, UACR= 2,3 (0-16,9) 
mg/g], međutim razlike nisu bile statistički značajne (p>0,05). Na osnovu rezultata 
može da se zaključi da se UACR može da koristi kao prognostički indikator trajanja 
SIRS kod štenadi sa CPVE. Međutim, neophodno je da se obavi  obuhvatnija studija, 
a radi potvrđivanja upotrebljivosti UALB i UACR u cilju procene kliničkog rizika kod 
štenadi sa CPVE. 
